Gallagher Fiduciary Advisors, LLC Pliant Therapeutics, Inc. Transaction History
Gallagher Fiduciary Advisors, LLC
- $485 Million
- Q4 2024
A detailed history of Gallagher Fiduciary Advisors, LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Gallagher Fiduciary Advisors, LLC holds 11,889 shares of PLRX stock, worth $37,688. This represents 0.03% of its overall portfolio holdings.
Number of Shares
11,889
Previous 10,009
18.78%
Holding current value
$37,688
Previous $112,000
39.29%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding PLRX
# of Institutions
175Shares Held
64.8MCall Options Held
228KPut Options Held
772K-
Deep Track Capital, LP Greenwich, CT5.97MShares$18.9 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$15.8 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.63MShares$14.7 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$10.2 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.2MShares$10.1 Million1.61% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $154M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...